CNS Pharmaceuticals, Inc.

CNSP

CNS Pharmaceuticals, Inc.

CNSP

Insider Sentiment (TTM):

Last Purchase:2026-05-18Last Sale:-Shares Purchased (TTM):7,100Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:145,596Shares Outstanding:676,172Institutional Ownership Pct.:21.53%

Earnings Market Reaction:

Filing Date:2026-08-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	20	3	7	10	12	13	6	7	1	1	1	1
Deferred Offering Costs	0	0	0	0	0	0	0	0	0	0	0	-
Common Stock Share Subscribed But Unissued Subscri…	-	-	0	-	-	-	1	-	-	-	0	-
Prepaid Expense And Other Assets Current	2	1	1	1	2	1	1	0	1	1	1	1
Assets Current	22	4	8	11	14	14	9	7	2	2	2	2
Assets Noncurrent
Prepaid Expense Noncurrent	0	1	1	0	0	0	0	0	0	0	0	0
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Assets Noncurrent	0	1	1	0	0	0	0	0	0	0	0	0
Assets	22	5	9	12	15	14	9	7	2	2	2	2
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	4	4	4	2	1	3	2	4	7	6	6	4
Notes Payable Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	4	5	4	2	1	3	3	4	7	6	6	4
Liabilities	4	5	4	2	1	3	3	4	7	6	6	4
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	126	105	105	104	104	100	91	85	71	69	65	62
Retained Earnings Accumulated Deficit	-108	-105	-100	-94	-91	-89	-84	-81	-76	-73	-70	-64
Stockholders Equity	18	0	5	10	13	11	6	3	-4	-4	-4	-2
Liabilities And Stockholders Equity	22	5	9	12	15	14	9	7	2	2	2	2
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	0	0	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	300	300	25	25	300	300	300	300	300	75	300	75
Common Stock Shares Issued	1	1	1	1	1	0	0	3	0	0	0	0
Shares Outstanding	1	1	1	1	1	0	0	3	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-0.20%	1.20%	-3.19%	-	-	-	-	-	-	-	-	-
2025	-17.46%	-26.98%	-49.07%	2.65%	48.51%	27.69%	-4.35%	-23.19%	-19.13%	-1.67%	126.78%	96.65%
2024	-49.50%	-87.80%	-97.49%	2.88%	-13.67%	-18.71%	-14.29%	3.36%	-20.17%	-19.85%	-19.12%	-43.31%
2023	-	-	-	-16.38%	-40.68%	12.99%	23.95%	-28.74%	-85.03%	-40.28%	-41.67%	-89.00%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	5.86	0.89	1.98	5.81	10.22	4.94	3.43	1.82	0.32	0.26	0.26	0.51
Quick Ratio	5.37	0.65	1.77	5.06	8.78	4.70	2.92	1.73	0.22	0.13	0.12	0.22
Working Capital	18.19M	-504.15K	4.00M	9.43M	12.75M	10.94M	6.13M	3.33M	-4.62M	-4.49M	-4.54M	-2.01M
Leverage & Debt
Debt to Equity	0.21	64.81	0.91	0.20	0.11	0.25	0.41	1.21	-1.58	-1.37	-1.38	-2.34
Interest Coverage TTM	-1,117.76	-1,098.53	-1,049.68	-874.29	-1,022.02	-999.47	-924.44	-1,052.64	-1,011.34	-1,166.03	-1,366.54	-1,406.79
Debt Ratio	0.17	0.98	0.48	0.17	0.10	0.20	0.29	0.55	2.74	3.67	3.61	1.75
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-2.44	-24.38	-35.75	-23.39	-41.77	-68.72	-466.89	-466.12	-25.56	-60,348.93	-150.17	-2,674.62
Free Cash Flow Per Share TTM	-1.76	-22.51	-31.15	-23.25	-47.60	-75.55	-537.90	-387.53	-17.21	-43,234.55	-112.67	-1,998.94
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	-	-	-	-	143.56%	-	-
Operating Profit Margin TTM	-	-	-	-	-	-	-221,392.71%	-124,381.17%	-60,062.37%	-50,797.41%	-68,137.06%	-90,018.25%
Net Profit Margin TTM	-	-	-	-	-	-	-220,736.90%	-124,202.18%	-60,014.83%	-50,740.97%	-68,086.92%	-89,982.24%
Growth Metrics
Net Revenue Growth (1Y)	-	-	-100.00%	-100.00%	-100.00%	-100.00%	-75.69%	-33.61%	241.14%	-	-	-
Net Income Growth (1Y)	8.03%	5.58%	6.68%	-23.37%	-3.22%	-10.59%	-21.18%	-8.36%	-8.77%	2.40%	23.42%	38.99%
EPS Growth (1Y)	-94.15%	-64.52%	-92.34%	-94.98%	63.42%	-99.89%	210.91%	-82.57%	-99.06%	1,023.95%	-97.77%	-55.60%
Valuation Metrics
P/E TTM	-1.96	-0.10	-0.15	-0.38	-0.24	-0.24	-0.15	-0.17	-37.09	-0.18	-253.71	-12.79
P/B TTM	1.80	22.86	0.51	0.51	0.28	0.34	0.37	0.86	-138.00	-0.71	-1,079.13	-136.72
P/S TTM	-	-	-	-	-	-	340.40	209.44	22,261.05	91.31	172,745.73	11,505.90
Market Cap	32.69M	1.62M	2.33M	5.03M	3.66M	3.71M	2.29M	2.88M	592.50M	3.14M	4.78B	238.00M
Enterprise Value	12.70M	-1.10M	-4.54M	-4.80M	-8.34M	-9.13M	-3.84M	-4.07M	591.13M	2.54M	4.78B	237.13M
Calculated Values
Free Cash Flow TTM	-12.01M	-15.22M	-13.81M	-12.99M	-17.62M	-17.17M	-17.12M	-14.18M	-10.76M	-12.51M	-14.14M	-13.91M
Net Debt	-19.99M	-2.72M	-6.87M	-9.83M	-12.01M	-12.84M	-6.14M	-6.94M	-1.37M	-602.12K	-247.92K	-867.64K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-18Purchase

Owner: Charles, Faith L.

Title: -

Shares: 7,100

Price/Share: $4.79

Value: $34,009.00

Shares Owned: 7,100

Relationship: Director

Ownership: Direct

2024-02-01Purchase

Owner: Gumulka, Jerzy

Title: -

Shares: 33,333

Price/Share: $0.30

Value: $9,999.90

Shares Owned: 43,006

Relationship: Director

Ownership: Direct

2024-02-01Purchase

Owner: Evans, Carl Anthony

Title: -

Shares: 33,333

Price/Share: $0.30

Value: $9,999.90

Shares Owned: 33,458

Relationship: Director

Ownership: Direct

2024-02-01Purchase

Owner: Downs, Christopher

Title: Chief Financial Officer

Shares: 66,666

Price/Share: $0.30

Value: $19,999.80

Shares Owned: 103,438

Relationship: Officer

Ownership: Direct

2024-02-01Purchase

Owner: Climaco, John M

Title: Chief Executive Officer

Shares: 166,666

Price/Share: $0.30

Value: $49,999.80

Shares Owned: 215,676

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-18	Charles, Faith L.	Director	-	Direct	Purchase	7,100	4.79	$34,009.00	7,100	4
2024-02-01	Gumulka, Jerzy	Director	-	Direct	Purchase	33,333	0.30	$9,999.90	43,006	4
2024-02-01	Evans, Carl Anthony	Director	-	Direct	Purchase	33,333	0.30	$9,999.90	33,458	4
2024-02-01	Downs, Christopher	Officer	Chief Financial Officer	Direct	Purchase	66,666	0.30	$19,999.80	103,438	4
2024-02-01	Climaco, John M	Director,Officer	Chief Executive Officer	Direct	Purchase	166,666	0.30	$49,999.80	215,676	4
2023-08-22	Downs, Christopher	Officer	Chief Financial Officer	Direct	Purchase	27,000	1.27	$34,290.00	36,772	4
2023-08-16	Climaco, John M	Director,Officer	Chief Executive Officer	Direct	Purchase	2,750	1.80	$4,950.00	49,010	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

21.53%

Inst. Shares: 145,596

Shares Outstanding: 676,172

2025-12-31

28.02%

Inst. Shares: 124,237

Shares Outstanding: 443,369

2025-09-30

4.40%

Inst. Shares: 24,616

Shares Outstanding: 558,868

2025-06-30

129.30%

Inst. Shares: 478,567

Shares Outstanding: 370,127

2025-03-31

17.87%

Inst. Shares: 40,594

Shares Outstanding: 227,220

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	145,596	676,172	21.53%
2025-12-31	124,237	443,369	28.02%
2025-09-30	24,616	558,868	4.40%
2025-06-30	478,567	370,127	129.30%
2025-03-31	40,594	227,220	17.87%
2024-12-31	2,370,389	31,823	-
2024-09-30	453,460	36,593	-
2024-06-30	144,154	625,000	23.06%
2024-03-31	856,590	289	-
2023-12-31	291,903	125,533	232.53%
2023-09-30	116,697	6,959	-
2023-06-30	82,525	6,460	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

CNS Pharmaceuticals, Inc. (CNSP) — SEC Financial Statements & Analysis

CNS Pharmaceuticals, Inc. (CNSP) is a pharmaceutical preparations company, incorporated in NV. CNS Pharmaceuticals, Inc. trades on Nasdaq as: CNSP. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), CNS Pharmaceuticals, Inc. reported a -100.00% year-over-year revenue growth, a Gross Profit Margin of 143.56% (TTM), a Debt-to-Equity ratio of 0.21x, a Price-to-Sales (P/S) ratio of 340.40x (TTM), a Price-to-Book (P/B) ratio of 1.80x (TTM), at a market cap of $32.69M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Gross Profit Margin TTM: 143.56%
Debt To Equity: 0.21x
P/S TTM: 340.40x
P/B TTM: 1.80x
Market Cap: $32.69M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CNS Pharmaceuticals, Inc. in?

CNS Pharmaceuticals, Inc. (CNSP) operates in the Pharmaceutical Preparations industry.

What is CNSP's market cap?

CNS Pharmaceuticals, Inc. (CNSP) has a market capitalization of $32.69M as of 2026-06-30.

What exchange does CNSP trade on?

CNS Pharmaceuticals, Inc. (CNSP) trades on the Nasdaq.

Where is CNS Pharmaceuticals, Inc. incorporated?

CNS Pharmaceuticals, Inc. is incorporated in NV.